swedish study on CFS/ME

Prof. Dr. Jonas Bergquist, University of Uppsala, Sweden, investigated antibodies against adrenergic receptors (a1, a2, b1, b2, b3) and acetylcholine muscarinergic receptors (M1-5) in two Swedish CFS/ME cohorts. For M3R-Ab and M4R-Ab a significant increase in antibody levels was found in CFS/ME patients compared to controls in both cohorts, for b1-adr-R-Ab and b2-adr-R-Ab only in…

CellTrend is a member of the “Network for Pharma Solutions”

The nationwide “Network for Pharma Solutions” (NetPhaSol), consists of 50 competent partners. The 20 research institutions and 30 companies including CellTrend are covering the entire value chain in drug discovery and development.   The “Network for Pharma Solutions” (NetPhaSol) starts campaign for networking and cooperation Are you looking for qualified partner for your project? Are…

New Research Article about HPV Vaccine and POTS/ CRPS

Human papillomavirus (HPV) infection promotes uterine and cervical cancers. In 2010, HPV vaccines were introduced worldwide. Since then case series of suspected adverse effects after HPV vaccination have been reported from several countries and the symptoms described by independent researchers are similar. In this study, autoantibodies against diverse Gprotein coupled receptors in the serum of…

New study in JAHA about POTS published

New study in Journal of American Heart Association about POTS published: Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G‐Protein Coupled Receptor Autoantibodies. William T. GunningIII , Heather Kvale , Paula M. Kramer , Beverly L. Karabin , and Blair P. Grubb The aim of this study was to detect both the presence and prevalence…

14th Dresden Symposium on Autoantibodies

Meet us at the 14th Dresden Symposium on Autoantibodies taking place from September 10 to September 13, 2019! The main topic of the upcoming symposium deals with the role of autoantibodies in precision health and precision medicine. Further topics: ★ Autoantibodies in systemic and organ specific autoimmune diseases (induction, pathology, clinical relevance) ★ Novel autoantibodies…

Professor title awarded

Dr. Kai Schulze-Forster, co-founder of CellTrend GmbH, was awarded the title of professor by the Technical University in Wildau. In a ceremonial act Prof. Dr. Ulrike Tippe, president of the TH Wildau, presented the certificate on Wednesday, 26th June 2019. The entire CellTrend Team congratulates Prof. Dr. Kai Schulze-Forster!

20th anniversary of CellTrend

On May 17, 2019, the 20th anniversary of CellTrend took place. Numerous cooperation partners, customers and friends found their way to Luckenwalde on this day to celebrate with us. The audience was offered very interesting speeches by renowned scientists. Therefore we would like to thank Prof. Dr. med. Yehuda Shoenfeld (Sheba Medical Center, Tel Aviv),…